About Cytosurge
Cytosurge is a company based in Zurich (Switzerland) founded in 2009 by Michael Gabi and Pascal Behr. It operates as a B2B and D2C. Cytosurge offers products and services including FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter. Cytosurge operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Zurich, Switzerland
- Founders Michael Gabi, Pascal Behr
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytosurge Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytosurge
Cytosurge offers a comprehensive portfolio of products and services, including FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter.
Platform for single-cell manipulation and biopsies
Service for CRISPR cell line engineering and knockouts
Tool for quoting cell editing services online
People of Cytosurge
Unlock access to complete
Funding Insights of Cytosurge
Investments & Acquisitions by Cytosurge
Financial Statements - Cytosurge
Cytosurge Comparisons
Competitors of Cytosurge
Cytosurge operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Frequently Asked Questions about Cytosurge
Cytosurge was founded in 2009.
Cytosurge is headquartered in Zurich, Switzerland.
Pascal Behr is the current CEO of Cytosurge. They have also founded this company.
Cytosurge AG specializes in developing and providing FluidFM technology for precise single-cell injection, extraction, and biopsies in life sciences. The company offers products like the FluidFM OMNIUM Platform and services such as CellEDIT for CRISPR-based cell line engineering. Based in Switzerland, it serves researchers and institutions by bridging genetic design tools with practical applications, focusing on synthetic biology and therapy manufacturing.
Cytosurge's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Cytosurge offers FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter.